Covered recipient · General Payments record
ALAN RICHARD SCHWARTZ
Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease
General Payments · PY2018–2024
$1,056,431.98
- Reported across 263 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $75,344.21 | 5 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $40,952.57 | 4 |
| Compensation for serving as faculty or as a speaker for a medical education program | $3,000.00 | 1 |
| Food and Beverage | $1,214.01 | 44 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Itamar Medical Inc | $65,093.15 | 1 |
| LivaNova USA, Inc. | $45,300.96 | 5 |
| Respicardia, Inc. | $9,081.38 | 5 |
| Acerta Pharma LLC | $190.86 | 9 |
| HARMONY BIOSCIENCES LLC | $188.13 | 6 |
| Takeda Pharmaceuticals U.S.A., Inc. | $135.18 | 4 |
| GlaxoSmithKline, LLC. | $92.80 | 5 |
| Regeneron Healthcare Solutions, Inc. | $64.30 | 3 |
| GENZYME CORPORATION | $52.16 | 2 |
| Grifols USA, LLC | $48.49 | 2 |
| Actelion Pharmaceuticals US, Inc. | $44.15 | 2 |
| TACTILE SYSTEMS TECHNOLOGY INC | $42.88 | 1 |
| JAZZ PHARMACEUTICALS INC. | $35.44 | 1 |
| Amgen Inc. | $24.22 | 1 |
| PFIZER INC. | $20.73 | 1 |
| Merck Sharp & Dohme Corporation | $18.28 | 1 |
| Genentech USA, Inc. | $17.90 | 1 |
| Avadel CNS Pharmaceuticals, LLC | $17.31 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.67 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.46 | 1 |
| Insmed, Inc. | $13.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.